Women with polycystic ovary syndrome have double the risk of liver disease

March 28, 2018, University of Birmingham
Credit: CC0 Public Domain

Scientists at the University of Birmingham have found that increased male hormones result in women with polycystic ovaries having a two-fold increased risk of developing non-alcoholic fatty liver disease.

Polycystic ovary syndrome (PCOS) affects 10 per cent of all and is known to cause irregular periods, impaired fertility, male-pattern body hair growth and acne. Many women who have PCOS have higher levels of male hormones, are less sensitive to insulin and are overweight or obese.

Non-alcoholic fatty liver disease is an umbrella term for a range of liver conditions affecting people who drink little or no alcohol and is a major cause of liver disease worldwide. The main characteristic of non-alcoholic fatty liver disease is too much fat stored in liver cells. Experts don't know exactly why some people accumulate fat in the liver while others do not, however non-alcoholic fatty liver disease has been linked to obesity.

Given the obesity link to both PCOS and non-alcoholic fatty liver disease, there is a strong interest in exploring the relationship between the two conditions, both in terms of prevalence and cause.

Now scientists have discovered that women with PCOS are two to three times more likely to develop non-alcoholic fatty liver disease than women without PCOS. And, importantly, the research found that women with both PCOS and a high testosterone level are at an increased risk of non-alcoholic fatty liver disease regardless of their weight.

In the largest study of its kind—published today in PLOS Medicine—the scientists compare the health records of 63,000 women with PCOS to 120,000 women of similar age, body weight and background. They also specifically looked at two cohorts of women with PCOS and women with high levels of testosterone.

Dr Krish Nirantharakumar, of the University of Birmingham's Institute of Applied Health, said: "We observed a two-fold increased risk of fatty liver disease in women with PCOS and male excess.

"Looking at the levels of the major male hormone testosterone, we found that having a high testosterone level increased the risk of fatty disease significantly, even in women who were of a normal healthy weight."

Professor Wiebke Arlt, Director of the University of Birmingham's Institute of Metabolism and Systems Research, said: "Our research has highlighted significant and previously unknown health risks in women with PCOS and increased male hormone levels.

"Our findings suggest that regular screening for should be considered in these women, to make sure the is caught early."

"Our research shows that PCOS does not only affect fertility but also comes with significantly increased rates of metabolic complications."

"This means that women with PCOS need integrated health care throughout their life and not only when planning pregnancy."

Explore further: Study uncovers link between male hormones and metabolic disease in polycystic ovary syndrome

More information: Kumarendran et al (2018). 'Polycystic ovary syndrome, androgen excess and risk of non-alcoholic fatty liver disease in women: longitudinal study based on a UK primary care database'. PLOS Medicine. doi.org/10.1371/journal.pmed.1002542

Related Stories

Study uncovers link between male hormones and metabolic disease in polycystic ovary syndrome

June 22, 2017
Scientists from the University of Birmingham have discovered the link between increased male hormones and metabolic complications such as diabetes and fatty liver disease in patients with polycystic ovary syndrome (PCOS).

Coexisting conditions signal future health trouble for girls

February 8, 2016
Researchers have found teenage girls with polycystic ovary syndrome (PCOS) are three-times more likely to have non-alcoholic fatty liver disease (NAFLD) than girls without PCOS.

PCOS may reduce gut bacteria diversity

January 23, 2018
Women who have a common hormone condition that contributes to infertility and metabolic problems tend to have less diverse gut bacteria than women who do not have the condition, according to a new study published in the Endocrine ...

Hormone from fat tissue can give protection against polycystic ovary syndrome

August 10, 2017
Obesity and reduced insulin sensitivity are common in polycystic ovary syndrome, PCOS. New research based on animal studies, and to be published in the journal PNAS, reveals that the hormone adiponectin can protect against ...

Study finds new class of androgens play key role in polycystic ovary syndrome

March 14, 2017
Scientists led by the University of Birmingham have discovered that a new class of male sex hormones known as androgens plays a key role in the development of polycystic ovary syndrome (PCOS).

Hirsutism strongly predicts metabolic dysfunction in PCOS

October 2, 2017
(HealthDay)—There is a strong correlation between hirsutism and metabolic dysfunction in women with polycystic ovary syndrome (PCOS), according to a study published online Sept. 21 in the Journal of Cosmetic Dermatology.

Recommended for you

Genetic flaw causes problems for many with hypothyroidism

October 23, 2018
With an estimated 120 million prescriptions filled each year, the thyroid medicine levothyroxine (marketed as Synthroid ) is one of the most popular prescription medicines in the United States. Most patients who suffer from ...

Collaboration yields possible treatment for rare neurodegenerative disorder

October 23, 2018
St. Jude Children's Research Hospital investigators have developed a new class of compounds that extended the lives and eased symptoms of mice with a progressive neurodegenerative human disorder. The findings appear today ...

Overweight or smoking mums cause 'worrying changes' to unborn children's thyroid

October 23, 2018
Smoking or being overweight during pregnancy causes 'worrying changes' to the development of the unborn baby's thyroids, and could predispose them to disease after birth, according to a new study from the University of Aberdeen.

'Game changer' tuberculosis drug cures 9 in 10

October 22, 2018
A new treatment for a drug-resistant strain of tuberculosis can cure more than 90 percent of sufferers, according to a trial hailed Monday as a "game changer" in the fight against the global killer.

AI doctor could boost chance of survival for sepsis patients

October 22, 2018
Scientists have created an artificial intelligence system that could help treat patients with sepsis.

Consuming caffeine from coffee reduces incident rosacea

October 22, 2018
(HealthDay)—Caffeine intake from coffee is inversely associated with the risk for incident rosacea, according to a study published online Oct. 17 in JAMA Dermatology.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.